Medicine and Dentistry
Acute B-Cell Lymphoblastic Leukemia
100%
B Cell
82%
T Cell
62%
Chimeric Antigen Receptor T-Cell
60%
Granulocyte Macrophage Colony Stimulating Factor
50%
Pediatrics
50%
Graft Versus Leukemia Effect
50%
Interferon
50%
Dendritic Cell
50%
Chimeric Antigen Receptor
50%
Acute Lymphoblastic Leukemia
50%
Event Free Survival
44%
Wilms' Tumor
33%
Tumor Protein
33%
Synapsin I
33%
Aplasia
32%
Minimal Residual Disease
29%
Spontaneous Remission
22%
Cytokine Release Syndrome
22%
Neurotoxicity
22%
Allogeneic Stem Cell Transplantation
20%
Acute Myeloid Leukemia
16%
Clinical Trial
16%
Cord Blood
16%
Lentivirus Vector
16%
Human Leukocyte Antigen
16%
B Cell Development
16%
Maturation
16%
Leukemia Antigen
16%
T Cell Development
16%
Allogeneic Hematopoietic Stem Cell Transplantation
16%
Hematopoietic Stem Cell Transplantation
16%
Leukapheresis
16%
Leukemia
16%
Integrase
16%
Adverse Effect
16%
Adverse Event
12%
Morphology
12%
Survival Rate
12%
Chimeric Antigen Receptor T-Cell Immunotherapy
12%
down Regulation
12%
Inotuzumab Ozogamicin
10%
Blinatumomab
10%
Hypogammaglobulinemia
10%
Engraftment
10%
Overall Survival
10%
T Cell Activation
10%
Genomic DNA
10%
Pharmacology, Toxicology and Pharmaceutical Science
Chimeric Antigen Receptor
100%
Acute Lymphoblastic Leukemia
100%
Interferon
50%
Granulocyte Macrophage Colony Stimulating Factor
50%
Leukemia
50%
Event Free Survival
36%
Remission
36%
Aplasia
26%
Tumor Protein
25%
Nephroblastoma
25%
Synapsin I
25%
Minimal Residual Disease
22%
Neurotoxicity
18%
Cytokine Release Syndrome
18%
Acute Myeloid Leukemia
12%
Leukocyte Antigen
12%
Good Manufacturing Practice
12%
NOD SCID Gamma Mouse
12%
Lentivirus Vector
12%
Integrase
12%
Clinical Trial
12%
Leukemia Antigen
12%
Mouse Model
12%
Survival Rate
10%
Adverse Event
10%
Inotuzumab Ozogamicin
8%
Overall Survival
8%
Immunoglobulin Deficiency
8%
Blinatumomab
8%
Genomic DNA
8%
Immunology and Microbiology
Dendritic Cell
50%
Interferon Type I
50%
B Cell
50%
T Cell
50%
Granulocyte Macrophage Colony-Stimulating Factor
50%
Humanized Mouse
16%
CD14
16%
CD34
16%
Maturation
16%
B Cell Development
16%
Leukemia Antigen
16%
Lentivirus Vector
16%
DNA Modification
16%
Mouse Model
16%
Leukapheresis
16%
T Cell Development
16%
Allogeneic Hematopoietic Stem Cell Transplantation
16%
Hematopoietic Stem Cell Transplantation
16%
Integrase
16%
Myeloid
16%
Human Leukocyte Antigen
16%
NSG Mouse
16%